Become a Member
Dark Mode
Become a Member
Members Only
Latest News
PM Modi in US
Special Projects
Neon
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
×
×
Johnson&Johnson
Maharashtra Cancels Johnson & Johnson's Baby Powder Manufacturing Licence
Johnson and Johnson To Stop Selling Talc Baby Powder Amid Cancer Lawsuits
ADVERTISEMENT
Two Doses Of J&J Shot Increases Protection Against Covid: Company
J&J’s Two-Dose Ebola Vaccine Regimen Safe: Study
FAQ: J&J Vaccine Approved for Emergency Use in India, How Effective is it?
Johnson & Johnson’s COVID-19 Vaccine Gets Approval for Emergency Use in India
J&J Applies for Emergency Use Approval of Its COVID Vaccine in India
J&J Recalls Some Sunscreens Due to Benzene Traces. Why Is It A Problem?
J&J Says Its COVID-19 Vaccine Effective Against Delta Variant
‘Still in Talks With Indian Govt’, Says J&J Regarding COVID Vaccine Approval
Indian Govt’s Indemnity ‘Doublespeak’: Why COVAXIN But Not Others?
US Backs COVID Jab Patents Waiver, What Next for Vaccine Equality?
Maharashtra Cancels Johnson & Johnson's Baby Powder Manufacturing Licence
Johnson and Johnson To Stop Selling Talc Baby Powder Amid Cancer Lawsuits
Two Doses Of J&J Shot Increases Protection Against Covid: Company
J&J’s Two-Dose Ebola Vaccine Regimen Safe: Study
FAQ: J&J Vaccine Approved for Emergency Use in India, How Effective is it?
Johnson & Johnson’s COVID-19 Vaccine Gets Approval for Emergency Use in India
ADVERTISEMENT
J&J Applies for Emergency Use Approval of Its COVID Vaccine in India
‘Still in Talks With Indian Govt’, Says J&J Regarding COVID Vaccine Approval
J&J Recalls Some Sunscreens Due to Benzene Traces. Why Is It A Problem?
J&J Says Its COVID-19 Vaccine Effective Against Delta Variant
Indian Govt’s Indemnity ‘Doublespeak’: Why COVAXIN But Not Others?
US Backs COVID Jab Patents Waiver, What Next for Vaccine Equality?
Load More
